AI
Monday, September 25, 2017 10:38:38 PM
ADRM ...bladerunner ...actual no longer in the stock ...so didn't benefit from the jump today . Forgot why I sold it ...probably got bored with it ...
Believe you were /are in KURA ...congrats on the jump on trial results .
Most of my focus is in FGEN , MYOK , OMER ...either because my wife works in Renal or I know someone connected to the Co..
I've posted about PLSE before ..actually discussed the Co with a Biotech CMO over taco's tonight ( we both have kids on the same soccer team so this was after practice ) ...anyway her view was not to dismiss their science or Robert Duggan .
If nothing else there may be a market treating Canine cancers as many pet owners in the US will often spend over $1,000 on CHOP treatments which usually fail ....but people spend the $ anyway....and I think about 50% of dogs develop some kind of cancer..
A real binary event is coming up with PRTO early next year . This is a stock you should only invest what you can afford to lose. BUT in this final , pivotal P 3 the bar is fairly low ...even 20% longer in fistula patency ( blood flow ) makes this clinically viable as the treatment will only cost about $600 and be done in less then a minute at the time of fistula creation.
Good luck
Kiwi
Believe you were /are in KURA ...congrats on the jump on trial results .
Most of my focus is in FGEN , MYOK , OMER ...either because my wife works in Renal or I know someone connected to the Co..
I've posted about PLSE before ..actually discussed the Co with a Biotech CMO over taco's tonight ( we both have kids on the same soccer team so this was after practice ) ...anyway her view was not to dismiss their science or Robert Duggan .
If nothing else there may be a market treating Canine cancers as many pet owners in the US will often spend over $1,000 on CHOP treatments which usually fail ....but people spend the $ anyway....and I think about 50% of dogs develop some kind of cancer..
A real binary event is coming up with PRTO early next year . This is a stock you should only invest what you can afford to lose. BUT in this final , pivotal P 3 the bar is fairly low ...even 20% longer in fistula patency ( blood flow ) makes this clinically viable as the treatment will only cost about $600 and be done in less then a minute at the time of fistula creation.
Good luck
Kiwi
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
